Omeros Corporation maintained with Strong Buy rating after securing a $2.1 billion partnership with Novo Nordisk for ...
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an ESMO Data Update and Third Quarter ...
Financially, Compass Pathways is well-capitalized with $221.9 million in cash, funding operations into 2027. Click here to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback